These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 20730071

  • 1. Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination.
    Cagnoni F, Njwe CA, Zaninelli A, Ricci AR, Daffra D, D'Ospina A, Preti P, Destro M.
    Vasc Health Risk Manag; 2010 Aug 09; 6():549-59. PubMed ID: 20730071
    [Abstract] [Full Text] [Related]

  • 2. Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.
    Bomback AS, Toto R.
    Am J Hypertens; 2009 Oct 09; 22(10):1032-40. PubMed ID: 19661925
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
    Horký K.
    Vnitr Lek; 2010 Feb 09; 56(2):120-6. PubMed ID: 20329582
    [Abstract] [Full Text] [Related]

  • 5. Update on role of direct renin inhibitor in diabetic kidney disease.
    Dhakarwal P, Agrawal V, Kumar A, Goli KM, Agrawal V.
    Ren Fail; 2014 Jul 09; 36(6):963-9. PubMed ID: 24678880
    [Abstract] [Full Text] [Related]

  • 6. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ, Smith SM, Choksi R.
    Expert Rev Cardiovasc Ther; 2009 Nov 09; 7(11):1373-84. PubMed ID: 19900020
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A.
    Expert Opin Pharmacother; 2007 Apr 09; 8(5):529-35. PubMed ID: 17376010
    [Abstract] [Full Text] [Related]

  • 8. Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control.
    Ferrario CM.
    Life Sci; 2010 Feb 27; 86(9-10):289-99. PubMed ID: 19958778
    [Abstract] [Full Text] [Related]

  • 9. Aliskiren in the treatment of hypertension and organ damage.
    Riccioni G.
    Cardiovasc Ther; 2011 Feb 27; 29(1):77-87. PubMed ID: 21106033
    [Abstract] [Full Text] [Related]

  • 10. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr 27; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 11. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M, Simioni N, Masiero A.
    Minerva Endocrinol; 2009 Dec 27; 34(4):333-8. PubMed ID: 20046162
    [Abstract] [Full Text] [Related]

  • 12. The antihypertensive effectiveness and safety of dual RAAS blockade with aliskiren and valsartan.
    Chrysant SG.
    Drugs Today (Barc); 2010 Mar 27; 46(3):151-62. PubMed ID: 20467589
    [Abstract] [Full Text] [Related]

  • 13. Current strategies to achieve further cardiac and renal protection through enhanced renin-angiotensin-aldosterone system inhibition.
    Alfie J, Aparicio LS, Waisman GD.
    Rev Recent Clin Trials; 2011 May 27; 6(2):134-46. PubMed ID: 21241234
    [Abstract] [Full Text] [Related]

  • 14. Updates on the treatment of essential hypertension: a summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors.
    Powers B, Greene L, Balfe LM.
    J Manag Care Pharm; 2011 Oct 27; 17(8 Suppl):S1-14. PubMed ID: 22088101
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Direct renin inhibition: focus on aliskiren.
    Pool JL.
    J Manag Care Pharm; 2007 Oct 27; 13(8 Suppl B):21-33. PubMed ID: 17970614
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
    Werner C, Pöss J, Böhm M.
    Drugs; 2010 Jul 09; 70(10):1215-30. PubMed ID: 20568830
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.